Arcellx

Investment area
Venture Investments
Region
North America
Date of investment
September 2017

Immuno-oncology company developing CAR T-Cell Therapy for treatment of Cancer.

Arcellx

Investment area
Venture Investments
Region
North America
Date of investment
September 2017

Immuno-oncology company developing CAR T-Cell Therapy for treatment of Cancer.

Arcellx

Investment area
Venture Investments
Region
North America
Date of investment
September 2017

Immuno-oncology company developing CAR T-Cell Therapy for treatment of Cancer.